FGFR3 and urinary bladder cancer: This case study demonstrates that the FGFR3 assay is a beneficial addition to the methodologies used in real-life clinical settings for diagnosing not only bladder cancer but also for diagnosing the less common and more difficult to detect upper urinary tract urothelial carcinoma.